New Therapeutic Approaches to the Treatment of Dyslipidemia 1: ApoC-III and ANGPTL3
Low-density lipoprotein cholesterol (LDL-C)-lowering therapy that increases LDL receptor expression in several ways robustly reduces the risk of atherosclerotic cardiovascular disease (CVD). However, a substantial risk of CVD still remains after intensive LDL-C reduction, which requires new treatmen...
-д хадгалсан:
| Үндсэн зохиолчид: | , |
|---|---|
| Формат: | Artigo |
| Хэл сонгох: | Inglês |
| Хэвлэсэн: |
The Korean Society of Lipid and Atherosclerosis
2023-01-01
|
| Цуврал: | Journal of Lipid and Atherosclerosis |
| Нөхцлүүд: | |
| Онлайн хандалт: | https://www.e-jla.org/search.php?where=aview&id=10.12997/jla.2023.12.1.23&code=9992JLA&vmode=FULL |
| Шошгууд: |
Шошго байхгүй, Энэхүү баримтыг шошголох эхний хүн болох!
|